Patents Assigned to Immunokick Incorporation
  • Patent number: 7919674
    Abstract: It is an object of the present invention to provide a high affinity antibody effective as a diagnostic or therapeutic for various diseases; a transgenic mammal for producing the high affinity antibody; and a medicine comprising the high affinity antibody or a cell producing the high affinity antibody. According to the present invention, a transgenic mammal carrying a GANP gene transferred thereinto, its progeny, or a part thereof, and a method of producing a high affinity antibody using the same are provided.
    Type: Grant
    Filed: November 7, 2003
    Date of Patent: April 5, 2011
    Assignee: Immunokick Incorporation
    Inventor: Nobuo Sakaguchi
  • Publication number: 20080233109
    Abstract: It is an object of the present invention to provide a high affinity antibody effective as a diagnostic or therapeutic for various diseases; a transgenic mammal for producing the high affinity antibody; and a medicine comprising the high affinity antibody or a cell producing the high affinity antibody. According to the present invention, a transgenic mammal carrying a GANP gene transferred thereinto, its progeny, or a part thereof, and a method of producing a high affinity antibody using the same are provided.
    Type: Application
    Filed: August 17, 2007
    Publication date: September 25, 2008
    Applicant: Immunokick Incorporation
    Inventor: Nobuo Sakaguchi
  • Publication number: 20060236417
    Abstract: It is an object of the present invention to provide a high affinity antibody effective as a diagnostic or therapeutic for various diseases; a transgenic mammal for producing the high affinity antibody; and a medicine comprising the high affinity antibody or a cell producing the high affinity antibody. According to the present invention, a transgenic mammal carrying a GANP gene transferred thereinto, its progeny, or a part thereof, and a method of producing a high affinity antibody using the same are provided.
    Type: Application
    Filed: November 7, 2003
    Publication date: October 19, 2006
    Applicant: Immunokick Incorporation
    Inventor: Nobuo Sakaguchi
  • Publication number: 20060040372
    Abstract: The object of the present invention is to provide a novel protein having a kinase activity and a gene encoding said protein. According to the present invention, there is provided a GANP protein which is represented by the arnino acid sequence shown in SEQ ID No. 1 or No. 3 of the sequence listing, and is involved in the signal conversion of abnormal B cell differentiation in an autoimmune state, and has a kinase activity, and a polynucleotide which encodes said protein.
    Type: Application
    Filed: July 13, 2005
    Publication date: February 23, 2006
    Applicant: IMMUNOKICK INCORPORATION
    Inventors: Nobuo Sakaguchi, Kazuhiko Kuwahara
  • Patent number: 6943237
    Abstract: The object of the present invention is to provide a novel protein having a kinase activity and a gene encoding said protein. According to the present invention, there is provided a GANP protein which is represented by the amino acid sequence shown in SEQ ID No. 1 or No. 3 of the sequence listing, and is involved in the signal conversion of abnormal B cell differentiation in an autoimmune state, and has a kinase activity, and a polynucleotide which encodes said protein.
    Type: Grant
    Filed: December 30, 2003
    Date of Patent: September 13, 2005
    Assignee: Immunokick Incorporation
    Inventors: Nobuo Sakaguchi, Kazuhiko Kuwahara